Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 947326, 2 pages
http://dx.doi.org/10.1155/2015/947326
Editorial

Rare Diseases of the Anterior Segment of the Eye: Update on Diagnosis and Management

1Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico, No. 155, 00196 Rome, Italy
2Department of Biology, College of Science and Technology, Temple University, 1900 N. 12th Street, Philadelphia, PA 19122, USA
3Cornea and Ocular Surface Unit, San Raffaele Hospital, Via Olgettina, No. 60, 20132 Milan, Italy
4Queen Alexandra Hospital, Southwick Hill Road, Cosham PO6 3LY, UK
5Scheie Eye Institute, University of Pennsylvania, 51 N. 39th Street, Philadelphia, PA 19104, USA

Received 17 August 2015; Accepted 24 August 2015

Copyright © 2015 Alessandro Lambiase et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Angelis, D. Tordrup, and P. Kanavos, “Socio-economic burden of rare diseases: a systematic review of cost of illness evidence,” Health Policy, vol. 119, no. 7, pp. 964–979, 2015. View at Publisher · View at Google Scholar
  2. S. M. Recupero, S. Abdolrahimzadeh, M. De Dominicis, and R. Mollo, “Sturge-Weber syndrome associated with naevus of Ota,” Eye, vol. 12, no. 2, pp. 212–213, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. A. Ito and M. A. Walter, “Genomics and anterior segment dysgenesis: a review,” Clinical & Experimental Ophthalmology, vol. 42, no. 1, pp. 13–24, 2014. View at Publisher · View at Google Scholar
  4. M. P. Ferrari, F. Mantelli, M. Sacchetti et al., “Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial,” BioDrugs, vol. 28, no. 3, pp. 275–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Rama, S. Matuska, G. Paganoni, A. Spinelli, M. De Luca, and G. Pellegrini, “Limbal stem-cell therapy and long-term corneal regeneration,” The New England Journal of Medicine, vol. 363, no. 2, pp. 147–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Sutherland and M. A. Day, “Genetic counseling and genetic testing in ophthalmology,” Current Opinion in Ophthalmology, vol. 20, no. 5, pp. 343–350, 2009. View at Google Scholar
  7. M. Sacchetti, I. Macchi, A. Tiezzi, M. La Cava, G. Massaro-Giordano, and A. Lambiase, “Pathophysiology of corneal dystrophies: from cellular genetic alteration to clinical findings,” Journal of Cellular Physiology, 2015. View at Publisher · View at Google Scholar
  8. A. Lambiase and M. Sacchetti, “Diagnosis and management of neurotrophic keratitis,” Clinical Ophthalmology, vol. 8, pp. 571–579, 2014. View at Publisher · View at Google Scholar
  9. R. W. Morris and M. T. Dunbar, “Atypical presentation and review of the ICE syndrome,” Optometry, vol. 75, no. 1, pp. 13–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. A. O'Connor, “Primary congenital glaucoma: making strides in genetic testing, early detection and treatment,” Insight, vol. 34, no. 1, pp. 11–13, 2009. View at Google Scholar · View at Scopus